安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Boxed Warning about mental health side effects for Singulair
FDA requires a Boxed Warning about serious mental health side effects for the asthma allergy drug Singulair (montelukast) Only take montelukast for hay fever if other medicines do not work or
- Singulair Black Box Warning: Risks and Why it Was Issued
Everything you need to know about the Singulair black box warning Learn the risks of Singulair and why the FDA issued the warning
- Singulair’s Dark Side: The Mental Health Warning the FDA Finally Added
In March 2020, the FDA slapped its strongest possible warning — a Boxed Warning, commonly called a black box warning — on Singulair (montelukast), a drug that had been prescribed to millions of Americans for asthma and allergies since 1998
- Singulair Gets Black Box Warning for Mental Health Side Effects - GoodRx
The FDA recently gave asthma medication montelukast (Singulair) a black box warning due to reports of depression and suicidal thoughts from the drug If you take Singulair, talk to your provider about possible alternatives
- A Boxed Warning for Montelukast: The FDA Perspective
FDA requires boxed warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis
- STATE OF NEW YORK OFFICE OF THE ATTORNEY GENERAL
It has been nearly four years since the U S Food and Drug Administration (FDA) strengthened existing warnings regarding the mental and behavioral health side effects of asthma and allergy drug montelukast (brand name Singulair) by imposing a black box warning, the strictest and most serious warning given to medications 1 Since that decision in
- New Warnings on Singulair Allergy and Asthma Drug
It warns about serious risks of a medication or treatment The black box warning for Singulair describes psychiatric side effects such as aggression, depression, agitation, sleep disturbances, suicidal thoughts, and suicide You can read Singulair’s complete black box warning here
- FDA requires Boxed Warning about serious mental health side effects for . . .
FDA is requiring a Boxed Warning stating that serious neuropsychiatric events that may include suicidal thoughts or actions have been reported in patients taking montelukast (Singulair)
|
|
|